These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 27640317)
21. Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies: incidence using different testing criteria, and case series. Joseph VMK; Rose EC; Edwards CJ; Lloyd M; Amar SK; Wheeler RD; Forster T; Smith KA; Eren E; Hughes R; Hajela V; Kiely PDW Clin Exp Rheumatol; 2022 Feb; 40(2):298-303. PubMed ID: 35200125 [TBL] [Abstract][Full Text] [Related]
22. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy. Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419 [TBL] [Abstract][Full Text] [Related]
23. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224 [TBL] [Abstract][Full Text] [Related]
24. Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy. Keating P; Young J; George P; Florkowski C; Spellerberg M; Kennedy N Int J Rheum Dis; 2017 Dec; 20(12):2179-2181. PubMed ID: 28185416 [No Abstract] [Full Text] [Related]
25. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy. Llansó L; Segarra-Casas A; Domínguez-González C; Malfatti E; Kapetanovic S; Rodríguez-Santiago B; de la Calle O; Blanco R; Dobrescu A; Nascimento-Osorio A; Paipa A; Hernandez-Lain A; Jou C; Mariscal A; González-Mera L; Arteche A; Lleixà C; Caballero-Ávila M; Carbayo Á; Vesperinas A; Querol L; Gallardo E; Olivé M Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200285. PubMed ID: 39106428 [TBL] [Abstract][Full Text] [Related]
26. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease. Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M Front Immunol; 2022; 13():866701. PubMed ID: 35603214 [TBL] [Abstract][Full Text] [Related]
27. Anti-HMGCR antibody-associated necrotizing myopathy: diagnosis and treatment illustrated using a case report. Giudizi MG; Cammelli D; Vivarelli E; Biagiotti R; Ferraro A; Bentow C; Almerigogna F; Albesa R; Mahler M Scand J Rheumatol; 2016 Oct; 45(5):427-9. PubMed ID: 26886059 [No Abstract] [Full Text] [Related]
28. HMGCR-associated myositis: a New Zealand case series and estimate of incidence. Kennedy N; Keating P; O'Donnell J Intern Med J; 2016 May; 46(5):622-5. PubMed ID: 27170241 [TBL] [Abstract][Full Text] [Related]
29. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697 [TBL] [Abstract][Full Text] [Related]
39. Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series. Tiniakou E; Rivera E; Mammen AL; Christopher-Stine L Arthritis Rheumatol; 2019 Oct; 71(10):1723-1726. PubMed ID: 31058470 [TBL] [Abstract][Full Text] [Related]
40. Statin-associated anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) myopathy: Imaging findings on thigh-muscle magnetic resonance imaging (MRI) in six patients. Lee KH; Gao Y; Lau V Muscle Nerve; 2021 Oct; 64(4):500-504. PubMed ID: 34297419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]